Literature DB >> 27982501

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

A Martin-Bastida1, N P Lao-Kaim1, C Loane1,2, M Politis1,3, A A Roussakis1, N Valle-Guzman4, Z Kefalopoulou5, G Paul-Visse6, H Widner7, Y Xing8, S T Schwarz8, D P Auer8, T Foltynie5, R A Barker9,10, P Piccini1.   

Abstract

BACKGROUND AND
PURPOSE: To determine whether iron deposition in deep brain nuclei assessed using high-pass filtered phase imaging plays a role in motor disease severity in Parkinson's disease (PD).
METHODS: Seventy patients with mild to moderate PD and 20 age- and gender-matched healthy volunteers (HVs) underwent susceptibility-weighted imaging on a 3 T magnetic resonance imaging scanner. Phase shifts (radians) in deep brain nuclei were derived from high-pass filtered phase images and compared between groups. Analysis of clinical laterality and correlations with motor severity (Unified Parkinson's Disease Rating Scale, Part III, UPDRS-III) were performed. Phase shifts (in radians) were compared between HVs and three PD subgroups divided according to UPDRS-III scores using analysis of covariance, adjusting for age and regional area.
RESULTS: Parkinson's disease patients had significantly (P < 0.001) higher radians than HVs bilaterally in the putamen, globus pallidus and substantia nigra (SN). The SN contralateral to the most affected side showed higher radians (P < 0.001) compared to the less affected side. SN radians positively correlated with UPDRS-III and bradykinesia-rigidity subscores, but not with tremor subscores. ancova followed by post hoc Bonferroni-adjusted pairwise comparisons revealed that SN radians were significantly greater in the PD subgroup with higher UPDRS-III scores compared to both lowest UPDRS-III PD and HV groups (P < 0.001).
CONCLUSIONS: Increased nigral iron accumulation in PD appears to be stratified according to disease motor severity and correlates with symptoms related to dopaminergic neurodegeneration. This semi-quantitative in vivo iron assessment could prove useful for objectively monitoring PD progression, especially in clinical trials concerning iron chelation therapies.
© 2016 EAN.

Entities:  

Keywords:  zzm321990SWIzzm321990; Parkinson's disease; iron; motor severity; neurodegeneration

Mesh:

Substances:

Year:  2016        PMID: 27982501     DOI: 10.1111/ene.13208

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  21 in total

1.  Multimodal dopaminergic and free-water imaging in Parkinson's disease.

Authors:  Jing Yang; Derek B Archer; Roxana G Burciu; Martijn L T M Müller; Arnab Roy; Edward Ofori; Nicolaas I Bohnen; Roger L Albin; David E Vaillancourt
Journal:  Parkinsonism Relat Disord       Date:  2019-01-06       Impact factor: 4.891

Review 2.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

3.  Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.

Authors:  Yu-Ting Chen; Wu-Yan Chen; Xiao-Tian Huang; Ye-Chun Xu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

Review 4.  Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Authors:  Paul Lingor; Eleonora Carboni; Jan Christoph Koch
Journal:  J Neural Transm (Vienna)       Date:  2017-02-06       Impact factor: 3.575

Review 5.  Structural Imaging in Parkinson's Disease: New Developments.

Authors:  Stéphane Prange; Elise Metereau; Stéphane Thobois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-18       Impact factor: 5.081

Review 6.  Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.

Authors:  Sara Pietracupa; Antonio Martin-Bastida; Paola Piccini
Journal:  Neurol Sci       Date:  2017-09-02       Impact factor: 3.307

Review 7.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2018-05-04       Impact factor: 8.401

Review 8.  Brain regions susceptible to alpha-synuclein spreading.

Authors:  Yu-Jie Guo; Huan Xiong; Kang Chen; Jin-Jun Zou; Peng Lei
Journal:  Mol Psychiatry       Date:  2021-09-24       Impact factor: 15.992

9.  Iron and inflammation: in vivo and post-mortem studies in Parkinson's disease.

Authors:  Antonio Martin-Bastida; Bension Shlomo Tilley; Sukhi Bansal; Steve M Gentleman; David T Dexter; Roberta J Ward
Journal:  J Neural Transm (Vienna)       Date:  2020-10-20       Impact factor: 3.575

10.  Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.

Authors:  Stefan Theodor Schwarz; Olivier Mougin; Yue Xing; Anna Blazejewska; Nin Bajaj; Dorothee P Auer; Penny Gowland
Journal:  Neuroimage Clin       Date:  2018-05-24       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.